BSPK
Price
$0.27
Change
-$0.02 (-6.90%)
Updated
Sep 25 closing price
Capitalization
3.01M
CANN
Price
$0.04
Change
-$0.00 (-0.00%)
Updated
Sep 26 closing price
Capitalization
4.44M
Interact to see
Advertisement

BSPK vs CANN

Header iconBSPK vs CANN Comparison
Open Charts BSPK vs CANNBanner chart's image
Bespoke Extracts
Price$0.27
Change-$0.02 (-6.90%)
Volume$1.98K
Capitalization3.01M
TREES
Price$0.04
Change-$0.00 (-0.00%)
Volume$116.67K
Capitalization4.44M
BSPK vs CANN Comparison Chart in %
Loading...
BSPK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CANN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BSPK vs. CANN commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSPK is a Buy and CANN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (BSPK: $0.27 vs. CANN: $0.04)
Brand notoriety: BSPK and CANN are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: BSPK: 6% vs. CANN: 54%
Market capitalization -- BSPK: $3.01M vs. CANN: $4.44M
BSPK [@Pharmaceuticals: Generic] is valued at $3.01M. CANN’s [@Pharmaceuticals: Generic] market capitalization is $4.44M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BSPK’s FA Score shows that 0 FA rating(s) are green whileCANN’s FA Score has 0 green FA rating(s).

  • BSPK’s FA Score: 0 green, 5 red.
  • CANN’s FA Score: 0 green, 5 red.
According to our system of comparison, both BSPK and CANN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BSPK’s TA Score shows that 6 TA indicator(s) are bullish while CANN’s TA Score has 4 bullish TA indicator(s).

  • BSPK’s TA Score: 6 bullish, 4 bearish.
  • CANN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BSPK is a better buy in the short-term than CANN.

Price Growth

BSPK (@Pharmaceuticals: Generic) experienced а +29.10% price change this week, while CANN (@Pharmaceuticals: Generic) price change was -1.76% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.16%. For the same industry, the average monthly price growth was +24.25%, and the average quarterly price growth was +66.99%.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CANN($4.44M) has a higher market cap than BSPK($3.01M). BSPK YTD gains are higher at: 344.079 vs. CANN (127.000). CANN has higher annual earnings (EBITDA): 619K vs. BSPK (-767.07K). CANN has more cash in the bank: 245K vs. BSPK (1.36K). BSPK has less debt than CANN: BSPK (1.46M) vs CANN (17.4M). CANN has higher revenues than BSPK: CANN (14.5M) vs BSPK (1.23M).
BSPKCANNBSPK / CANN
Capitalization3.01M4.44M68%
EBITDA-767.07K619K-124%
Gain YTD344.079127.000271%
P/E RatioN/AN/A-
Revenue1.23M14.5M9%
Total Cash1.36K245K1%
Total Debt1.46M17.4M8%
FUNDAMENTALS RATINGS
BSPK vs CANN: Fundamental Ratings
BSPK
CANN
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
67
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
3438
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
450

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CANN's Valuation (67) in the null industry is in the same range as BSPK (96). This means that CANN’s stock grew similarly to BSPK’s over the last 12 months.

CANN's Profit vs Risk Rating (100) in the null industry is in the same range as BSPK (100). This means that CANN’s stock grew similarly to BSPK’s over the last 12 months.

CANN's SMR Rating (99) in the null industry is in the same range as BSPK (100). This means that CANN’s stock grew similarly to BSPK’s over the last 12 months.

BSPK's Price Growth Rating (34) in the null industry is in the same range as CANN (38). This means that BSPK’s stock grew similarly to CANN’s over the last 12 months.

BSPK's P/E Growth Rating (100) in the null industry is in the same range as CANN (100). This means that BSPK’s stock grew similarly to CANN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BSPKCANN
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
87%
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
89%
Advances
ODDS (%)
Bullish Trend 17 days ago
80%
Bullish Trend 6 days ago
84%
Declines
ODDS (%)
Bearish Trend 12 days ago
88%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
BSPK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CANN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BIOA5.420.20
+3.83%
BioAge Labs Inc.
SPSC106.321.37
+1.31%
SPS Commerce
HBIO0.44N/A
+1.07%
Harvard Bioscience
ONC326.06-2.65
-0.81%
BeOne Medicines Ltd
PBT18.51-0.19
-1.02%
Permian Basin Royalty Trust

BSPK and

Correlation & Price change

A.I.dvisor tells us that BSPK and OVATF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BSPK and OVATF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSPK
1D Price
Change %
BSPK100%
N/A
OVATF - BSPK
21%
Poorly correlated
N/A
BKUH - BSPK
8%
Poorly correlated
N/A
AVCNF - BSPK
5%
Poorly correlated
+4.68%
CANN - BSPK
4%
Poorly correlated
+2.15%
CAIHF - BSPK
2%
Poorly correlated
N/A
More

CANN and

Correlation & Price change

A.I.dvisor tells us that CANN and CVSI have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CANN and CVSI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CANN
1D Price
Change %
CANN100%
+2.15%
CVSI - CANN
23%
Poorly correlated
N/A
MEDIF - CANN
21%
Poorly correlated
-2.58%
CNTMF - CANN
14%
Poorly correlated
-6.00%
CAIHF - CANN
12%
Poorly correlated
N/A
BIOGY - CANN
9%
Poorly correlated
N/A
More